Search Results

The True Prevalence of PAD and the Economics of Major Amputation

Mary L. Yost, MBA, presents an evidence-based approach to amputation, sharing her estimate of the current prevalence of peripheral artery disease, the impact of amputation on health care costs, and potential reimbursement changes.

Determining Cost-Effectiveness in CLI Therapy

Weighing clinical benefits along with cost when selecting therapies is more important than ever.

By Firas F. Mussa, MD, MS, with commentary by Mary L. Yost, MBA

Cost-Benefit Analysis of Critical Limb Ischemia in the Era of the Affordable Care Act

Is it fiscally responsible to perform primary amputation as treatment?

By Mary L. Yost, MBA

Cost-Benefit Analysis of Critical Limb Ischemia in the Era of the Affordable Care Act

Is it fiscally responsible to perform primary amputation as treatment?

By Mary L. Yost, MBA

Cost-Benefit Analysis of Critical Limb Ischemia in the Era of the Affordable Care Act

Is it fiscally responsible to perform primary amputation as treatment?

By Mary L. Yost, MBA

Cost-Benefit Analysis of Critical Limb Ischemia in the Era of the Affordable Care Act

Is it fiscally responsible to perform primary amputation as treatment?

By Mary L. Yost, MBA

Amputation Prevention & Limb Preservation

By Jos C. van den Berg, MD, PhD

CLI: Where We Stand

By Jihad A. Mustapha, MD

The Contemporary CLI Toolbox

A close look at the available devices and techniques for treating today's critical limb ischemia patients.

By David E. Allie, MD; Raghotham R. Patlola, MD; Agostino Ingraldi, MD; Chris J. Hebert, RT(R), RCIS; and Craig M. Walker, MD

Perspectives: Robotics in Practice

A discussion with experts who are exploring the utility and benefits of robotically assisted intervention in their practice.

With Barry T. Katzen, MD, FACC, FACR, FSIR, and Theodore L. Schreiber, MD, FACC, FSCAI

Optimal Medical Therapy for CLI: Recent Advances and the Need for More Data

A conversation with the President of the Society for Vascular Medicine on current best practices for medical therapy in this challenging population.

With Heather L. Gornik, MD

Ask the Experts:

What is your go-to option for treating in-stent restenosis?

With Antonio Micari, MD, PhD; Prof. Dr. med. Nicolas Diehm; Michael H. Wholey, MD, MBA; Jos C. van den Berg, MD, PhD; and Andrew J. Feiring, MD, FACC, FSCAI, FAHA

Vascular Intervention and Women's Health

By Maureen P. Kohi, MD, FSIR

From Patient Selection to Fibroid-Level Prediction: Defining the Era of Precision UFE

Advances in imaging, procedural customization, and artificial intelligence are transforming uterine fibroid embolization into a precision medicine intervention, enabling more accurate patient selection, optimized technique, and improved clinical outcomes.

By Dominie Miyasato; Erica M. Knavel Koepsel, MD; Gretchen M. Foltz, MD; and Dania Daye, MD

Innovations

A preview of today's new products.

Challenge Accepted

By John A. Kaufman, MD

Therapeutic Choice Is Quality Claudication Care

Exercise and claudication pharmacotherapies as the foundation to redefine conservative care.

By Mudassar Ahmed, MD; Sara Murray, MD; and Alan T. Hirsch, MD